Cefadroxil Capsule500 mg / 50 Count
Back to Products
Brand name: Duricef®
Cefadroxil is indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases:
Urinary tract infections caused by E. coli, P. mirabilis, and Klebsiella species.
Skin and skin structure infections caused by staphylococci and/or streptococci.
Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci).
For more information please see the prescribing information on DailyMed.
|Product Name||Cefadroxil Capsule|
|Pack Size||50 Count|
|Gluten||Free from Gluten|
|Lactose||Free from Lactose|
|Soy||Free from Soy|
|Allergen Info||Free from dairy products and egg products|
|Other Product Info||Not Applicable|
Lactose monohydrate, magnesium stearate, FD&C Blue no. 1, D&C Red no. 28, FD&C Red no. 40, titanium dioxide, gelatin, sodium lauryl sulfate, ferrosoferric oxide
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
|Product Shelf Life||24 months|
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.